Harmony Biosciences Holdings, Inc.
HRMY NASDAQ







Weekly Report
Harmony Biosciences Holdings, Inc. closed at 32.5400 (0.12% WoW) . Data window ends Fri, 19 Sep 2025.
How to read this โ Price slope is downward, indicating persistent supply pressure. Low weekly volatility favours steadier follow-through. Volume trend diverges from price โ watch for fatigue or rotation. Returns are positively correlated with volume โ strength tends to arrive on higher activity. Distance to baseline is narrowing โ reverting closer to its fair-value track. Fresh short-term downside crossover weakens near-term tone. Price sits below key averages, keeping pressure on the tape.
Down-slope argues for patience; rallies can fade sooner unless participation improves. Because liquidity isnโt confirming, prefer evidence of fresh demand before chasing moves.
Gauge maps the trend signal to a 0โ100 scale.
How to read this โ Range-bound conditions; conviction is limited until a break or acceleration emerges.
Wait for a directional break or improving acceleration.
Price is below fair value; potential upside if momentum constructive.
Conclusion
Neutral setup. โ โ โ โโ confidence. Price window: -5. Trend: Range / Neutral; gauge 68. In combination, liquidity diverges from price.
- Momentum is bullish and rising
- Low return volatility supports durability
- Price is not above key averages
- Liquidity diverges from price
- Negative multi-week performance
Why: Price window -5.41% over 8w. Close is -14.30% below the prior-window high. Return volatility 1.62%. Volume trend rising. Liquidity divergence with price. Trend state range / neutral. 4โ8w crossover bearish. Momentum bullish and rising. Valuation supportive skew.
Tip: Most metrics include a hover tooltip where they appear in the report.